Dominika Misztela: Germany is also one of the very few countries in the EU which collects sufficient plasma to supply its patients’ needs for essential PDMP’s

Dominika Misztela, Senior Director of Global Regulatory Policy at Plasma Protein Therapeutics Association, recently shared a post on LinkedIn:

“Delighted to have been able to present at this year’s ARGE Plasmapherse congress on the forthcoming soho regulation.

ARGE Plasmapherese is truly unique and shows that it can be done: Collaboration and Co-existence to benefit patients’ needs. ARGE Plasmapherese brings together the public blood and plasma collection services, the private plasma industry and key experts from the transfusion and plasmapheresis fields in Germany to collaboratively discuss key issues, trends and give recommendations to decision-making bodies.

Germany is also one of the very few countries in the EU which collects sufficient plasma to supply its patients’ needs for essential prescription drug monitoring programs (PDMP’s).”

For more information click here.
Source: Dominika Misztela/LinkedIn.